RxDoctor Payments Data

Alexandra Gillespie, MD

Cytopathology · Dallas, TXNPI 1154345841

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 5 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 4 manufacturers reported payments, led by Endologix LLC at 50.2% of the total. 2024 is the largest year on record at $201, 9.7 times the $21 reported in 2019.

$261in general payments, 2019–2025

Across 5 payments — averaging $52.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Endologix LLC$131
  • Hologic Sales And Service, LLC$70
  • Roche Diagnostics Corporation$47
  • Smith+Nephew$13

What the payments were for

  • Food & beverage$261100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$261 in reported general payments places this provider in the 70th percentile of 24 cytopathology providers in Texas.

See all cytopathology providers in Texas

Medicare billing

Part B allowed, 2024
$516,161
Medicare patients
4,548
Services billed
15,927

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other cytopathology in Dallas

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →